AUPQ344799A0 - Treatment of respiratory diseases and infections - Google Patents
Treatment of respiratory diseases and infectionsInfo
- Publication number
- AUPQ344799A0 AUPQ344799A0 AUPQ3447A AUPQ344799A AUPQ344799A0 AU PQ344799 A0 AUPQ344799 A0 AU PQ344799A0 AU PQ3447 A AUPQ3447 A AU PQ3447A AU PQ344799 A AUPQ344799 A AU PQ344799A AU PQ344799 A0 AUPQ344799 A0 AU PQ344799A0
- Authority
- AU
- Australia
- Prior art keywords
- infections
- treatment
- respiratory diseases
- respiratory
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPQ3447A AUPQ344799A0 (en) | 1999-10-15 | 1999-10-15 | Treatment of respiratory diseases and infections |
AU10074/01A AU1007401A (en) | 1999-10-15 | 2000-10-16 | Treatment of respiratory diseases and infections |
PCT/AU2000/001254 WO2001028584A1 (en) | 1999-10-15 | 2000-10-16 | Treatment of respiratory diseases and infections |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPQ3447A AUPQ344799A0 (en) | 1999-10-15 | 1999-10-15 | Treatment of respiratory diseases and infections |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPQ344799A0 true AUPQ344799A0 (en) | 1999-11-11 |
Family
ID=3817604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPQ3447A Abandoned AUPQ344799A0 (en) | 1999-10-15 | 1999-10-15 | Treatment of respiratory diseases and infections |
Country Status (2)
Country | Link |
---|---|
AU (1) | AUPQ344799A0 (en) |
WO (1) | WO2001028584A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1435969A4 (en) * | 2001-09-20 | 2006-08-16 | Inologic Inc | Method of modulating sodium ion absorption in epithelial cells |
AUPS022802A0 (en) * | 2002-01-31 | 2002-02-21 | Macfarlane Burnet Institute For Medical Research And Public Health Limited, The | Anti-viral compounds |
US6858615B2 (en) | 2002-02-19 | 2005-02-22 | Parion Sciences, Inc. | Phenyl guanidine sodium channel blockers |
US20090253714A1 (en) * | 2003-08-20 | 2009-10-08 | Johnson Michael R | Methods of reducing risk of infection from pathogens |
US7745442B2 (en) | 2003-08-20 | 2010-06-29 | Parion Sciences, Inc. | Methods of reducing risk of infection from pathogens |
US7682619B2 (en) | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
DE102008034265A1 (en) * | 2008-07-22 | 2010-01-28 | Beiersdorf Ag | Active substance combination of aniseed extract and hyaluronic acid |
AR086745A1 (en) | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-DIAMINO-6-CHLORINE-N- (N- (4- (4- (2- (HEXIL (2,3,4,5,6-PENTAHYDROXIHEXIL)) AMINO) ETOXI) PHENYL) BUTIL) CARBAMIMIDOIL) PIRAZINA -2-CARBOXAMIDE |
MX2015007797A (en) | 2012-12-17 | 2015-10-05 | Parion Sciences Inc | 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds. |
WO2014099676A1 (en) | 2012-12-17 | 2014-06-26 | Parion Sciences, Inc. | Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration |
US9102633B2 (en) | 2013-12-13 | 2015-08-11 | Parion Sciences, Inc. | Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds |
CN106924337A (en) * | 2017-04-12 | 2017-07-07 | 江苏农牧科技职业学院 | Application of the yellow bark of ash in the medicine for preparing treatment livestock and poultry virus sexually transmitted disease |
-
1999
- 1999-10-15 AU AUPQ3447A patent/AUPQ344799A0/en not_active Abandoned
-
2000
- 2000-10-16 WO PCT/AU2000/001254 patent/WO2001028584A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001028584A1 (en) | 2001-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7748000A (en) | Method and composition for the treatment of dermatologic diseases | |
AUPQ415899A0 (en) | Compositions for and methods of treatment of allergic diseases | |
AU3632600A (en) | Compositions and methods for the treatment of immune related diseases | |
AUPQ344799A0 (en) | Treatment of respiratory diseases and infections | |
AU3896900A (en) | Treatment of pain | |
AU2281601A (en) | Treatment of viral infections using levovirinTM | |
AU7106300A (en) | Treatment of skin disorders | |
AU3434601A (en) | Compositions and methods for the treatment of immune related diseases | |
PL349910A1 (en) | Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections | |
AU2003213898A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
AU2001267165A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
AU1405001A (en) | Treatment of diseases | |
AU2001258575A1 (en) | Treatment of cancer and neurological diseases | |
GB9908059D0 (en) | Diagnosis and treatment of diseases | |
AU2001267177A1 (en) | Diagnosis and treatment of herpes infections | |
AU1007401A (en) | Treatment of respiratory diseases and infections | |
AU5611701A (en) | Agent for the diagnosis and therapy of viral diseases | |
AU1039601A (en) | Medicaments for treatment of respiratory syncytial virus infections | |
AU1392601A (en) | Prevention and treatment of biomaterial-associated infections | |
AU2003255111A1 (en) | The use of n-acetyl-d-glucosamine for preparing medicines for urogenital tract infection's treatment and prevention | |
AU2908501A (en) | Combination therapy for the treatment of inflammatory and respiratory diseases | |
AU3524700A (en) | Prevention and treatment of viral infections | |
AU2728301A (en) | Combination therapy for the treatment of inflammatory and respiratory diseases | |
AU2001218422A1 (en) | Antiviral and antibacterial pharmaceutical preparation "armenicum" and its use for treatment of infectious diseases | |
AUPQ423199A0 (en) | Compositions for the treatment of infectious and/or skin diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAA1 | Application designating australia and claiming priority from australian document |
Ref document number: 1007401 Country of ref document: AU |